Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 168
Filtrar
1.
Molecules ; 26(23)2021 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-34885770

RESUMO

Epilobium angustifolium L. is a popular medicinal plant found in many regions of the world. This plant contains small amounts of essential oil whose composition and properties have not been extensively investigated. There are few reports in the literature on the antioxidant and antifungal properties of this essential oil and the possibility of applying it as a potential promoter of the skin penetration of drugs. The essential oil was obtained by distillation using a Clavenger type apparatus. The chemical composition was analyzed by the GC-MS method. The major active compounds of E. angustifolium L. essential oil (EOEa) were terpenes, including α-caryophyllene oxide, eucalyptol, ß-linalool, camphor, (S)-carvone, and ß-caryophyllene. The analyzed essential oil was also characterized by antioxidant activity amounting to 78% RSA (Radical Scavenging Activity). Antifungal activity against the strains Aspergillus niger, A. ochraceus, A. parasiticum, and Penicillium cyclopium was also determined. The largest inhibition zone was observed for strains from the Aspergillus group. The EOEa enhanced the percutaneous penetration of ibuprofen and lidocaine. After a 24 h test, the content of terpene in the skin and the acceptor fluid was examined. It has been shown that the main compounds contained in the essential oil do not penetrate through the skin, but accumulate in it. Additionally, FTIR-ATR analysis showed a disturbance of the stratum corneum (SC) lipids caused by the essential oil application. Due to its rich composition and high biological activity, EOEa may be a potential candidate to be applied, for example, in the pharmaceutical or cosmetic industries. Moreover, due to the reaction of the essential oil components with SC lipids, the EOEa could be an effective permeation enhancer of topically applied hydrophilic and lipophilic drugs.


Assuntos
Epilobium/química , Micoses/tratamento farmacológico , Óleos Voláteis/química , Extratos Vegetais/química , Antifúngicos/química , Antifúngicos/farmacologia , Antioxidantes/química , Antioxidantes/farmacologia , Aspergillus/efeitos dos fármacos , Aspergillus/patogenicidade , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Micoses/microbiologia , Óleos Voláteis/farmacologia , Penicillium/efeitos dos fármacos , Penicillium/patogenicidade , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Pele/efeitos dos fármacos , Absorção Cutânea/efeitos dos fármacos , Terpenos/química , Terpenos/farmacologia
3.
Intern Emerg Med ; 16(6): 1619-1627, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33751395

RESUMO

Blot and colleagues have proposed putative invasive pulmonary aspergillosis (PIPA) definitions for troublesome diagnosis in suspected patients outside the classical criteria of immunosuppression. We retrospectively included in the study all admitted patients with an Aspergillus spp. positive culture within lower airway samples. Overall, Aspergillus spp. positivity in respiratory samples was 0.97 every 1000 hospital admissions (HA): 4.94 and 0.28/1000/HA, respectively, in intensive care units (ICUs) and medical wards (MW). 66.6% fulfilled PIPA criteria, and 33.4% were defined as colonized. 69.2% of PIPA diagnosis occurred in the ICU. Antifungal therapy was appropriate in 88.5% of subjects with PIPA and 37.5% of colonized, confirming the comparison between deads and lives. Patients with PIPA in the ICUs had more frequent COPD, sepsis or septic shock, acute kidney injury (AKI), needed more surgery, mechanical ventilation (MV), vasopressors, hemodialysis, blood or platelets transfusions. PIPA in MW had associated with a history of smoking, interstitial lung disease and inhaled steroid therapy. Overall mortality within 21 days was 50%: 54.2% in ICU, 36,8% in MW. Factors associated with death were length of hospitalization, influenza, pneumonia, liver transplant, AKI, ARDS, sepsis and septic shock. PIPA in the ICU had higher disease severity and needed more organ support than MW cases, despite that cases of PIPA in MW are emerging with trends difficult to demonstrate given the problematic diagnosis.


Assuntos
Aspergilose Pulmonar Invasiva/diagnóstico , Idoso , Aspergilose/diagnóstico , Aspergilose/epidemiologia , Aspergillus/efeitos dos fármacos , Aspergillus/patogenicidade , Aspergillus flavus/efeitos dos fármacos , Aspergillus flavus/patogenicidade , Aspergillus niger/efeitos dos fármacos , Aspergillus niger/patogenicidade , Feminino , Humanos , Unidades de Terapia Intensiva/organização & administração , Unidades de Terapia Intensiva/estatística & dados numéricos , Aspergilose Pulmonar Invasiva/epidemiologia , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Quartos de Pacientes/organização & administração , Quartos de Pacientes/estatística & dados numéricos , Estudos Retrospectivos , Fatores de Risco , Estatísticas não Paramétricas
4.
Am J Trop Med Hyg ; 104(3): 871-873, 2021 01 04.
Artigo em Inglês | MEDLINE | ID: mdl-33399044

RESUMO

Mycetoma is an infrequent subcutaneous infection caused by true fungi (eumycetoma) or aerobic actinomycetes (actinomycetoma). We report the case of a 62-year-old man with eumycetoma involving the left foot and ankle. Skin biopsy revealed black-brown grains, and in culture, a white colony fungus grew at day 8. Molecular sequencing using ITS1-ITS4 primers identified the species as Aspergillus sydowii. The patient was treated with itraconazole 200 mg twice daily and terbinafine 250 mg daily for 8 months, with complete response and no recurrence after 2.5 years of follow-up. Aspergillus sydowii is a saprotrophic fungus that rarely causes skin or nail disease. No cases of eumycetoma caused by this agent have been previously reported. As its geographic distribution continues to expand, it may increasingly be recognized as a cause of human disease.


Assuntos
Tornozelo/fisiopatologia , Aspergillus/patogenicidade , Pé/fisiopatologia , Itraconazol/uso terapêutico , Micetoma/diagnóstico , Micetoma/tratamento farmacológico , Micetoma/fisiopatologia , Terbinafina/uso terapêutico , Tornozelo/microbiologia , Antifúngicos/uso terapêutico , Feminino , Pé/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
5.
PLoS One ; 15(11): e0242862, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33232384

RESUMO

Bunch rot in grapes is an aggressive disease and needs to be controlled during the postharvest period. We investigate the antifungal potential of Zanthoxylum bungeanum Maxim., Zanthoxylum rhetsa, Cuminum cyminum, Coriandrum sativum, and Zingiber montanum (J. Koenig) Link ex A. Dietr. essential oils against Aspergillus aculeatus that cause bunch rot disease on postharvest grapes. C. cyminum essential oil exhibited stronger significantly inhibition percentage of 95.08% than other treatments in in vitro assay. Cumin aldehyde (33.94%) and α-terpinen-7-al (32.20%) were identified as major volatile compounds in C. cyminum oil. Antifungal potential of C. cyminum oil was then tested in conidia germination and in vitro tests compared to cumin aldehyde and α-terpinen-7-al. Their EC50 values against the conidial germination were also estimated. Significant reduction of conidia germination was also detected in C. cyminum essential oil and cumin aldehyde at a concentration of 1,000 and 100 µg/mL, respectively. EC50 values of the C. cyminum essential oil, cumin aldehyde, and α-terpinen-7-al were 67.28 µg/mL, 9.31 µg/mL, and 13.23 µg/mL, respectively. In vivo assay, the decrease of the disease severity (0.69%) and incidence (1.48%) percentage of A. aculeatus on grape berries treated at 1,000 µg/mL of C. cyminum essential oil was significantly greater than that obtained from other treatments after 10 days incubation. In addition, grape berries treated with C. cyminum essential oil decreased weight loss and retained fruit firmness. The changing of total soluble solids, total phenolic content, and antioxidant activity are also delayed in treated fruits. Therefore, essential oil of C. cyminum may be applied as a biological antifungal agent to control A. aculeatus in postharvest grapes without any negative effects on its quality.


Assuntos
Cuminum/química , Óleos Voláteis/farmacologia , Doenças das Plantas/prevenção & controle , Vitis/efeitos dos fármacos , Antifúngicos/química , Antifúngicos/farmacologia , Aspergillus/efeitos dos fármacos , Aspergillus/patogenicidade , Humanos , Óleos Voláteis/química , Doenças das Plantas/microbiologia , Vitis/crescimento & desenvolvimento , Vitis/microbiologia
6.
Mycoses ; 63(10): 1021-1032, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32744334

RESUMO

The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant risk factors for breakthrough IFIs in haematology patients, solid organ transplant recipients, and patients in the intensive care unit, focusing particularly on host factors, and highlight areas that require future investigation.


Assuntos
Infecções Fúngicas Invasivas , Corticosteroides/efeitos adversos , Antifúngicos/uso terapêutico , Aspergillus/isolamento & purificação , Aspergillus/patogenicidade , Candida/isolamento & purificação , Candida/patogenicidade , Cateteres Venosos Centrais/efeitos adversos , Cateteres Venosos Centrais/microbiologia , Equinocandinas/uso terapêutico , Fluconazol/uso terapêutico , Fusarium/isolamento & purificação , Fusarium/patogenicidade , Predisposição Genética para Doença , Neoplasias Hematológicas/complicações , Humanos , Hospedeiro Imunocomprometido , Unidades de Terapia Intensiva , Infecções Fúngicas Invasivas/diagnóstico , Infecções Fúngicas Invasivas/tratamento farmacológico , Infecções Fúngicas Invasivas/epidemiologia , Infecções Fúngicas Invasivas/prevenção & controle , Mucorales/isolamento & purificação , Mucorales/patogenicidade , Micoses/diagnóstico , Micoses/tratamento farmacológico , Micoses/epidemiologia , Micoses/prevenção & controle , Neutropenia/complicações , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/epidemiologia , Infecções Oportunistas/microbiologia , Infecções Oportunistas/prevenção & controle , Transplante de Órgãos/efeitos adversos , Penicillium/isolamento & purificação , Penicillium/patogenicidade , Fatores de Risco , Triazóis/uso terapêutico
7.
PLoS One ; 15(7): e0236319, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32726328

RESUMO

Jacaranda mimosifolia trees are grown in frost-free regions globally. The aim of this study was to evaluate the methanol crude extract and various fractions of increasing polarity of J. mimosifolia leaves for bioactive metabolites, as well as antimicrobial, antioxidant and anticancer activities. The anti-inflammatory potential of the various fractions of J. mimosifolia leaf extract was studied via the lipoxygenase (LOX) inhibitory assay. Methanol crude extract (ME), derived fractions extracted with chloroform (CF) and ethyl acetate (EAF), and residual aqueous extract (AE) of dried J. mimosifolia leaves were assayed for polyphenolic compounds, their antioxidant, antimicrobial and lipoxygenase (LOX) inhibitory activities, and anticancer properties. Polyphenolic compounds were determined via HPLC while phytochemicals (total phenolics, flavonoids, tannins and ortho-diphenol contents), antioxidant activities (DPPH, hydrogen peroxideperoxide, hydroxyl and superoxide radical anions) and LOX were measured via spectrophotometry. Methanol extracts and various fractions were evaluated for antibacterial activities against Bacillus subtilis, Klebsiella pneumonia, Pseudomonas aeruginosa and Staphylococcus aureus. Antifungal potential of the fractions was tested against three species: Aspergillus flavus, Aspergillus fumigatus and Fusarium oxysporum. The highest values for total phenolic content (TPC), total flavonoid content (TFC), flavonols, tannins and ortho-diphenols were in the ME, followed by CF > EAF > AE. ME also had the highest antioxidant activity with EC50 values 48±1.3, 45±2.4, 42±1.3 and 46±1.3 µg/mL based on the DPPH, hydrogen peroxide, hydroxyl radical and superoxide radical assays, respectively. TPC and TFC showed a significant, strong and positive correlation with the values for each of these antioxidant activities. ME exhibited anti-inflammatory potential based on its LOX inhibitory activity (IC50 = 1.3 µg/mL). ME also had the maximum antibacterial and antifungal potential, followed by EAF > CF > AE. Furthermore, ME showed the strongest cytotoxic effect (EC50 = 10.7 and 17.3 µg/mL) against human hormone-dependent prostate carcinoma (LnCaP) and human lung carcinoma (LU-1) cell lines, respectively. Bioactive compounds present in leaf methanol extracts of J. mimosifolia were identified using gas chromatography-mass spectrometry (GC-MS). Fifteen compounds were identified including phenolic and alcoholic compounds, as well as fatty acids. Our results suggest that J. mimosifolia leaves are a good source of natural products with antioxidant, anti-inflammatory and anti-cancer properties for potential therapeutic, nutraceutical and functional food applications.


Assuntos
Anti-Infecciosos/farmacologia , Antioxidantes/farmacologia , Bignoniaceae/química , Extratos Vegetais/farmacologia , Anti-Infecciosos/química , Antioxidantes/química , Aspergillus/efeitos dos fármacos , Aspergillus/patogenicidade , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Citotoxinas/química , Citotoxinas/farmacologia , Humanos , Inibidores de Lipoxigenase/química , Inibidores de Lipoxigenase/farmacologia , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Extratos Vegetais/química , Folhas de Planta/química , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/patogenicidade
8.
Mycoses ; 63(8): 787-793, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32458510

RESUMO

BACKGROUND: Invasive mould infections (IMIs) are very rare in patients with lymphoid malignancies. However, IMIs, mostly due to Aspergillus species, have been increasingly reported in such patients receiving ibrutinib (IBR). There is paucity of information regarding non-Aspergillus invasive mould infections (NAIMIs) in this setting, OBJECTIVES: To review our recent experience and the published literature on the topic. PATIENTS/METHODS: We present a case of invasive sinusitis caused by Fusarium in a patient with refractory chronic lymphocytic leukaemia (CLL) who was treated with IBR and review the 12 published cases of NAIMIs during IBR. RESULTS: Nearly all cases of NAIMIs in the setting of IBR use were encountered in patients with CLL. Mixed fungal infections, brain involvement and late-onset infections were common. CONCLUSIONS: Although rare, NAIMIs should be considered in patients who receive IBR.


Assuntos
Adenina/análogos & derivados , Aspergilose , Leucemia Linfocítica Crônica de Células B/complicações , Micoses/etiologia , Piperidinas/efeitos adversos , Adenina/efeitos adversos , Idoso , Anticarcinógenos/efeitos adversos , Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/etiologia , Aspergillus/isolamento & purificação , Aspergillus/patogenicidade , Feminino , Fungos/isolamento & purificação , Fungos/patogenicidade , Fusariose/tratamento farmacológico , Fusariose/etiologia , Fusarium/isolamento & purificação , Fusarium/patogenicidade , Humanos , Leucemia Linfocítica Crônica de Células B/tratamento farmacológico , Mucorales/isolamento & purificação , Mucorales/patogenicidade
9.
Mycopathologia ; 185(2): 399-403, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31925638

RESUMO

Invasive aspergillosis (IA) is the most common invasive fungal infection following a hematopoietic cell transplant, with emerging cryptic species exhibiting resistance to commonly used antifungals such as azoles. These species have been increasingly found after the introduction of anti-mold prophylaxis. We report a case of a 56-year-old female with primary myelofibrosis whose allogeneic hematopoietic cell transplant was complicated by disseminated fungal infection (skin, lung) due to Aspergillus calidoustus, a cryptic specie. Treatment of Aspergillus species remains challenging as these cryptic species are usually resistant to azoles including voriconazole which is the first line of treatment of IA. Infection was successfully treated with surgical excision and combination antifungal therapy based on in vitro susceptibility and synergy testing. Therapy included isavuconazole, a drug that has been shown to be non-inferior to voriconazole in the treatment of invasive mold infections.


Assuntos
Aspergilose , Aspergillus , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Infecções Fúngicas Invasivas , Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Aspergilose/patologia , Aspergillus/isolamento & purificação , Aspergillus/patogenicidade , Azóis/uso terapêutico , Farmacorresistência Fúngica , Feminino , Humanos , Infecções Fúngicas Invasivas/tratamento farmacológico , Infecções Fúngicas Invasivas/patologia , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Nitrilas/uso terapêutico , Mielofibrose Primária/complicações , Piridinas/uso terapêutico , Triazóis/uso terapêutico
10.
Mycopathologia ; 185(1): 187-192, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31297666

RESUMO

Dermatophytic granuloma characterized by perifollicular granulomatous inflammation was first described by Domenico Majocchi and was later named after him, Majocchi's granuloma (MG). Although the initial description was related to a dermatophyte Trichophyton tonsurans, later reports linked MG to non-dermatophytes (Phoma, Aspergillus, Malbranchea), which led to a confusion of disease patterns caused by cutaneous pathogens and general opportunistic microorganisms. Furthermore, several causative agents of MG described in the literature were not confirmed as such. Our review addressed the following aspects: (1) significance of histopathological finding for MG diagnosis, (2) dermatophytes as exclusive agents of MG, (3) spectrum of etiological agents causing different types of invasive dermatophytic infections, and (4) treatment options.


Assuntos
Granuloma/diagnóstico , Granuloma/microbiologia , Arthrodermataceae/patogenicidade , Aspergillus/patogenicidade , Humanos , Micetoma/diagnóstico , Micetoma/microbiologia , Tinha/diagnóstico , Tinha/microbiologia
11.
Folia Microbiol (Praha) ; 65(1): 109-120, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31073843

RESUMO

The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates.


Assuntos
Líquido da Lavagem Broncoalveolar/microbiologia , Neoplasias Hematológicas/complicações , Neoplasias Hematológicas/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Aspergillus/genética , Aspergillus/isolamento & purificação , Aspergillus/patogenicidade , DNA Fúngico/genética , Feminino , Galactose/análogos & derivados , Humanos , Unidades de Terapia Intensiva , Masculino , Mananas/análise , Pessoa de Meia-Idade , Neutropenia/microbiologia , Pneumocystis carinii/genética , Pneumocystis carinii/isolamento & purificação , Pneumocystis carinii/patogenicidade , Pneumonia por Pneumocystis/diagnóstico , Pneumonia por Pneumocystis/microbiologia , Estudos Retrospectivos , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/isolamento & purificação , Streptococcus pneumoniae/patogenicidade , Adulto Jovem
12.
Zhongguo Fei Ai Za Zhi ; 22(12): 772-778, 2019 Dec 20.
Artigo em Chinês | MEDLINE | ID: mdl-31874673

RESUMO

BACKGROUND: The aim of this study is to explore the pathogenic bacteria type, distribution, drug resistance and influencing factors of nosocomial pulmonary infection in patients with lung cancer during chemotherapy. METHODS: This study retrospectively analyzed the clinical data of 411 patients with lung cancer who were hospitalized in the First Affiliated Hospital of Zhejiang University Medical College from January 2017 to December 2018, and counted the incidence of nosocomial lung infection, pathogens, drug resistance and influencing factors. RESULTS: There were 184 cases of nosocomial pulmonary infection in 411 lung cancer patients during chemotherapy, the infection rate was 44.77%. The isolated pathogens included Gram-negative bacteria, Gram-positive bacteria, viruses, fungi and tuberculosis, among which Gram-negative bacteria accounted for 37.25%, followed by virus infection, accounting for 15.69%. Pseudomonas aeruginosa and Klebsiella pneumoniae are the main Gram-negative bacteria, Staphylococcus aureus and Streptococcus pneumoniae are the common gram-positive bacteria, influenza B virus is the main virus, Candida and Aspergillus are the most common fungi. The resistance rate of Pseudomonas aeruginosa to imipenem was 26.67%, while that of Klebsiella pneumoniae to imipenem was 12.50%, and that of the main Gram-positive bacteria to vancomycin was 0.00%. Hypoproteinemia, long chemotherapy cycle, high-intensity chemotherapy, chronic obstructive pulmonary disease and basic bronchiectasis were the high risk factors of lung cancer patients with nosocomial pulmonary infection during chemotherapy (P<0.05). CONCLUSIONS: During the chemotherapy of lung cancer patients with nosocomial pulmonary infection, the distribution and drug resistance of pathogenic bacteria have certain characteristics. Clinicians should strengthen the detection of pathogenic bacteria and their drug resistance. On the basis of symptomatic treatment, to achieve the purpose of ensuring the treatment effect and prolonging the survival period of patients, preventive measures should be taken for high-risk patients to reduce the chemotherapy cycle and intensity as much as possible to reduce the incidence of infection life.


Assuntos
Neoplasias Pulmonares/microbiologia , Neoplasias Pulmonares/virologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Aspergillus/patogenicidade , Candida/patogenicidade , Feminino , Bactérias Gram-Negativas/patogenicidade , Bactérias Gram-Positivas/patogenicidade , Humanos , Vírus da Influenza B/patogenicidade , Masculino , Pessoa de Meia-Idade , Pneumonia/microbiologia , Estudos Retrospectivos , Staphylococcus aureus/patogenicidade , Adulto Jovem
14.
Postgrad Med J ; 95(1125): 382-389, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31221685

RESUMO

Aspergillus is a rare but important opportunistic pathogen to invade the central nervous system (CNS). It is a significant pathogen of not only immunocompromised but also immunocompetent patients. Its manifestations are pleiotropic, reflecting multiple mechanisms of pathogenesis and host interactions. Despite significant advances in diagnostic methods and therapeutic options, the mortality remains high. Several advances have been made in medications and surgical management, yet, current treatment practices lack uniformity. Patient woes are further heightened by the high costs of treatment and prolonged duration of therapy. In view of the challenging aspects of this disease, we present a short review of four challenging cases touching on the varied aspects of management of CNS aspergillosis covering pathogenesis, diagnostic pitfalls, surgical and medical options and evidence-based guidelines for the management of the same.


Assuntos
Antifúngicos/uso terapêutico , Aspergillus/patogenicidade , Encéfalo/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Neuroaspergilose/diagnóstico , Neuroaspergilose/tratamento farmacológico , Adulto , Aspergillus/efeitos dos fármacos , Encéfalo/microbiologia , Encéfalo/patologia , Bases de Dados Factuais , Gerenciamento Clínico , Seguimentos , Humanos , Hospedeiro Imunocomprometido , Masculino , Neuroaspergilose/epidemiologia , Estudos Retrospectivos , Medição de Risco , Estudos de Amostragem , Índice de Gravidade de Doença , Resultado do Tratamento
15.
Gene ; 711: 143934, 2019 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-31228540

RESUMO

Phytopathogenic fungi secrete a wide range of enzymes to penetrate and colonize host tissues. Of them protease activity is reported to increase disease aggressiveness in the plant. With the aim to explore the reason of the higher infection potential of proteases, we have compared several genomic and proteomic attributes among different hydrolytic enzymes coded by five pathogenic fungal species which are the potent infectious agents of plant. Categorizing the enzymes into four major groups, namely protease, lipase, amylase and cell-wall degraders, we observed that proteases are evolutionary more conserved, have higher expression levels, contain more hydrophobic buried residues, short linear motifs and post-translational modified (PTM) sites than the other three groups of enzymes. Again, comparing these features of protease between pathogenic and non-pathogenic Aspergillus sps, we have hypothesized that protein structural properties could play significant roles in imposing infection potency to the fungal proteases.


Assuntos
Aspergillus/patogenicidade , Biologia Computacional/métodos , Peptídeo Hidrolases/química , Peptídeo Hidrolases/genética , Aspergillus/classificação , Aspergillus/genética , Simulação por Computador , Sequência Conservada , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Perfilação da Expressão Gênica/métodos , Regulação Neoplásica da Expressão Gênica , Interações Hidrofóbicas e Hidrofílicas , Filogenia , Conformação Proteica , Processamento de Proteína Pós-Traducional , Proteômica/métodos
16.
Hig. aliment ; 33(288/289): 2842-2845, abr.-maio 2019. graf
Artigo em Português | LILACS, VETINDEX | ID: biblio-1482349

RESUMO

A castanha-do-brasil é uma matéria-prima de origem amazônica, conhecida por seus benefícios nutricionais. Entretanto, por conta da produção extrativista este produto está susceptivel a vários focos de contaminação durante a cadeia produtiva. Este trabalho teve como objetivos a avaliação de diferentes métodos de descontaminação para controle de Aspergillus nomius produtor de aflatoxinas em castanha-do-brasil. As amostras de castanhas foram inoculadas com suspensão de A. nomius e posteriormente, foram testadas as técnicas de secagem em estufa a 60°C por 8 horas, esterilização em cabine UV por 20 minutos e sanitização com hipoclorito de sódio a 200 ppm por 15 minutos. Todos os tratamentos tiveram ação sob a cepa, sendo obtidos reduções de 3,18; 1,66 e 1,04 RD, respectivamente. A secagem mostrou-se o melhor tratamento de descontaminação, no entanto, mais pesquisas com outros métodos de descontaminação em castanhas são necessárias para controle da contaminação fúngica.


Assuntos
Aflatoxinas/antagonistas & inibidores , Aspergillus/patogenicidade , Bertholletia/microbiologia , Descontaminação/métodos , Microbiologia de Alimentos
17.
J Pediatr Hematol Oncol ; 41(5): 345-354, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30973485

RESUMO

Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in children with cancer. An overview of studies on the frequency and determinants of IFI in pediatric oncology patients in nonallogeneic stem cell transplantation settings is lacking. We performed a literature review in Pubmed and Embase, and included 13 prospective and 23 retrospective studies. The IFI frequency (proven/probable based on EORTC criteria) in nonallogeneic stem cell transplantation pediatric cancer patients ranged between 1.0% and 38.0%, with the highest frequencies reported in hematologic malignancies. The most common fungal species seen in the studied population was Candida, followed by Aspergillus. IFI are not well investigated in solid tumor patients. Significant recurrent determinants from univariate analysis were the diagnosis acute myeloid leukemia, (prolonged) neutropenia and an older age (above 10 years). The only 2 significant determinants based on multivariate analysis were the preceding number of days of broad-spectrum antibiotics (odds ratio, 1.05; 95% confidence interval, 1.02-1.07; P=0.0006) and the number of days of corticosteroids (odds ratio, 1.05; 95% confidence interval, 1.02-1.09; P=0.005), that were both based on a group of acute myeloid leukemia patients only. Future studies are necessary to determine the frequency and determinants of IFI in pediatric oncology including a representative number of solid tumor patients.


Assuntos
Neoplasias Hematológicas/complicações , Transplante de Células-Tronco Hematopoéticas/métodos , Infecções Fúngicas Invasivas/etiologia , Neoplasias/complicações , Adolescente , Corticosteroides/efeitos adversos , Fatores Etários , Antibacterianos/efeitos adversos , Aspergillus/patogenicidade , Candida/patogenicidade , Criança , Neoplasias Hematológicas/microbiologia , Humanos , Infecções Fúngicas Invasivas/epidemiologia , Leucemia Mieloide Aguda/complicações , Neoplasias/microbiologia , Neutropenia/complicações , Fatores de Risco
18.
J Infect Chemother ; 25(7): 547-551, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30824299

RESUMO

Aspergillus fumigatus is the commonest cause of pulmonary aspergillosis; however, a recently developed molecular genetic technique identified A. lentulus as a sibling species. Most of the isolates were found in solid organ recipients, often associated with a fatal outcome. Moreover, there is concern that A. lentulus has low susceptibility to multiple antifungal agents. Herein, we report an adult immunocompromised patient with proven invasive pulmonary aspergillosis (IPA) caused by A. lentulus, which was identified through molecular genetic analysis. The patient was diagnosed with IPA by bronchoscopy 3 weeks after initiating systemic corticosteroid therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis. The clinical course of IPA due to A. lentulus showed improvement after treatment with the antifungal agent voriconazole. In summary, we report an adult immunocompromised patient without a history of transplantation who was diagnosed with IPA due to A. lentulus successfully treated with voriconazole, and we also report the findings of a literature review on IPA caused by A. lentulus.


Assuntos
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/tratamento farmacológico , Aspergillus/patogenicidade , Glucocorticoides/efeitos adversos , Aspergilose Pulmonar Invasiva/microbiologia , Idoso de 80 Anos ou mais , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/imunologia , Antifúngicos/uso terapêutico , Aspergillus/isolamento & purificação , Broncoscopia , Evolução Fatal , Feminino , Humanos , Hospedeiro Imunocomprometido , Aspergilose Pulmonar Invasiva/diagnóstico , Aspergilose Pulmonar Invasiva/imunologia , Pulmão/diagnóstico por imagem , Pulmão/microbiologia , Tomografia Computadorizada por Raios X , Voriconazol/uso terapêutico
19.
Arq. bras. oftalmol ; 82(1): 2-5, Jan.-Feb. 2019. tab
Artigo em Inglês | LILACS | ID: biblio-973875

RESUMO

ABSTRACT Purpose: To determine whether a correlation exists between pathogenic species and clinical findings, disease severity, and visual outcome in patients with keratitis and fungal growth in microbiological culture. Methods: A retrospective study of patients with fungal growth in the microbiological culture of corneal scrapings. Patients were treated at an ophthalmologic reference center in Southeastern Brazil from January 1992 to October 2015. Results: Medical records of 181 patients (131 males and 50 females) with a mean age of 47 ± 18 years were analyzed. The three most common etiologies were Fusarium sp. (38.7%), Aspergillus sp. (15%), and Candida sp. (13.2%). Among these, Fusarium sp. was the most frequent in patients aged £50 years (p=0.002) and in those with a recent history of a foreign body and/or ocular trauma (p=0.01). Candida sp. was the most frequent etiology in patients aged >50 years (p=0.002), in those with postoperative ocular surgery (p=0.002); in those with a previous ocular pathology (p=0.0007); and in immunodepressed patients (p=0.0004). Conclusion: Fusarium sp. was predominant in patients aged £50 years and those with a recent history of foreign body and/or ocular trauma, whereas Candida sp. was predominant in older adults, in those with a postoperative ocular surgery, in those with a previous ocular pathology, and in immunodepressed patients.


RESUMO Objetivo: Determinar se existe uma correlação entre espécies patogênicas e achados clínicos, gravidade da doença e resultado visual em pacientes com ceratite e crescimento de fungos em cultura microbiológica. Métodos: Estudo retrospectivo de pacientes com crescimento de fungos na cultura microbiológica de raspado de córnea. Os pacientes foram tratados em um centro de referência oftalmológica no Sudeste do Brasil de janeiro de 1992 a outubro de 2015. Resultados: Foram analisados registros médicos de 181 pacientes (131 homens e 50 mulheres) com idade média de 47 ± 18 anos. As três etiologias mais comuns foram Fusarium sp. (38,7%), Aspergillus sp. (15%) e Candida sp. (13,2%). Entre estas, Fusarium sp. foi a mais frequente em pacientes com idade £50 anos (p=0,002) e naqueles com história recente de corpo estranho e/ou trauma ocular (p=0,01). Candida sp. foi a etiologia mais frequente em pacientes com idade >50 anos (p=0,002), naqueles com cirurgia ocular pós-operatória (p=0,002); naqueles com patologia ocular prévia (p=0,0007); e em pacientes imunodeprimidos (p=0,0004). Conclusão: Fusarium sp. foi predominante em pacientes com idade £50 anos e naqueles com história recente de corpo estranho e/ou trauma ocular; enquanto Candida sp. foi predominante em adultos mais velhos, naqueles com cirurgia ocular pós-operatória, naqueles com patologia ocular prévia e em pacientes imunodeprimidos.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Infecções Oculares Fúngicas/microbiologia , Infecções Oculares Fúngicas/patologia , Úlcera da Córnea/microbiologia , Úlcera da Córnea/patologia , Aspergillus/patogenicidade , Índice de Gravidade de Doença , Candida/patogenicidade , Acuidade Visual , Infecções Oculares Fúngicas/tratamento farmacológico , Úlcera da Córnea/tratamento farmacológico , Corpos Estranhos no Olho/microbiologia , Corpos Estranhos no Olho/patologia , Estudos Retrospectivos , Fatores de Risco , Lesões da Córnea/microbiologia , Lesões da Córnea/patologia , Fusarium/patogenicidade , Antifúngicos/uso terapêutico
20.
Nat Prod Res ; 33(21): 3077-3082, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30251547

RESUMO

Two novel compounds, 2-hydroxy-6-formyl-vertixanthone (1) and 12-O-acetyl-sydowinin A (2), were obtained from the culture of a deep sea-derived fungus Aspergillus sydowii C1-S01-A7, together with twenty-two known compounds (3-24). Their structures were elucidated based on extensive spectroscopic methods. Compounds 4, 8 and 12 showed antibacterial activities against Vibrio rotiferianus and Vibrio vulnificus. Compounds 1, 2, 7, 8, 11 and 12 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus. Remarkably, compound 8 displayed selectively cytotoxic activity against A549 and strongest cytotoxic activities for both A549 and HepG2 in comparison to the remaining compounds.


Assuntos
Aspergillus/metabolismo , Metabolismo Secundário , Células A549 , Antibacterianos/química , Antibacterianos/farmacologia , Organismos Aquáticos/metabolismo , Aspergillus/química , Aspergillus/patogenicidade , Células Hep G2 , Humanos , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Estrutura Molecular , Vibrio/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA